Latest News
Lilly Surges on EU Leukemia Drug Approval; Pre-Market Nears Analyst Target
Eli Lilly shares jumped 7.13% to a record $1,208.12 Friday, adding $75.7B in market cap after EU regulators recommended Jaypirca for chronic lymphocytic leukemia.
Apple Stock Steady Amid $100 Billion Buyback and DRAM Policy Risks
Apple shares held steady near $284 after a 3.14% Friday surge, as a $100 billion buyback plan offsets rising DRAM costs and policy risks from a potential CXMT deal.
South Korea's $518B Chip Plan Fails to Impress Investors
South Korea's revised 800 trillion won ($518.3B) chip plan, down 60% from earlier estimates, sent Samsung down 4.86% and SK Hynix down 1.68% as investors focused on capex load.
Hormuz Tanker Imbalance Sparks Oil Glut Fears as Brent Edges Higher
Brent crude rose 0.6% to $72.44 as U.S.-Iran strikes disrupted Hormuz shipping, but a growing tanker imbalance—four ships leaving for every one arriving—raises glut risks and threatens supply restart.
SpaceX Launches SiriusXM Satellite, Shifting Focus to Service Timeline
SpaceX launched SiriusXM's SXM-11 satellite, eliminating launch risk. The market's attention now turns to how quickly the satellite begins service, with the 74-day SXM-10 benchmark in focus.
NASA's $30M Swift Rescue Mission Could Pave Way for Satellite Servicing
NASA's $30 million contract with Katalyst Space aims to boost the Swift satellite, testing a scalable rescue model that could save billions in replacement costs.
NASA Awards $30M Satellite Boost Contract; SpaceX Launches Sirius XM Satellite
NASA contracts Katalyst Space for a satellite boost mission, SpaceX launches SXM-11 for Sirius XM, oil prices rise on Hormuz tanker imbalances, and Lazard offers a high dividend yield amid financial concerns.
Federal Loan Caps Shift Grad Students to Private Lenders
Starting July 1, new caps on federal Grad PLUS loans will force many graduate and professional students to seek private financing, potentially boosting originations at Sallie Mae and SoFi.